Amphion Innovations Share Discussion Threads

[21trader] 19/3/2015 18:09

Mind you it's complicated stuff isis had a grip on it from memory.

For now it's buy the dips sell the spikes.

[21trader] 19/3/2015 18:07

There's several potential payments to AMP which could be multiple's of the market cap and many multiples.

But the liabilities in the balance balance out the reward risk. Think they were over 20 million. (just checked they are over 20 million)

Worth reading last set of results.

[cottoner] 19/3/2015 17:57

AMP also have a 11.51% holding in KMK currently worth approx £4.5M , which basically covers AMP's current MCAP of £4.5M on its own.

On top of that is the Motif Bio holding and their 5 other partnerships and their ownership of Datatern.

[21trader] 19/3/2015 16:17

So it is. So nearer a 10 mil market cap then.

Will wait and see if that is confirmed by the company.

[the stigologist] 19/3/2015 16:15

NOMINAL VALUE = 1 pence

ISSUE PRICE = 20 pence

[the stigologist] 19/3/2015 16:14

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):



Securities to be admitted: TBC

Nominal value of securities: 1p

Issue price: 20p

Shares in treasury: Nil

There are no restrictions on the transfer of securities

[21trader] 19/3/2015 15:50

I love flops twitter posts he is totally shameless and never close to the mark
he is incapable of posting how it really is.

stig

I think somewhere between 10-20 million is my guess. I think 20p is the nominal
value of the shares not the actual float price but what do I know could be miles
out on that. We have to wait and see but 60 million it would be a lottery win if
they got that value float away.

[the stigologist] 19/3/2015 15:44

there is some straightforward lying going on here

the pump and dumpers talking about a market cap for motif of £60m but the actual holding value attributable to AMP according to the Schedule 1 RNS is

28m shares x 20p = £5m

and the total value of Motif will be about £10m

Given that AMP will be a forced seller the stock should trade at a discount to any supposed listed value

[moreforus] 19/3/2015 15:05

Topinfo ‏@TopTradersADVFN 4m4 minutes ago
If you own 56% of a company thats going to be valued at £60 Million and thats just one holding from many what should you be valued at eh AMP
1 retweet 0 favorites
Reply Retweeted1 Favorite
More

[21trader] 19/3/2015 15:04

Got a few more out must thank the pump and dumpers and flops.

Buy back if it dips below 2.75p again.

[cottoner] 19/3/2015 12:32

Recent Interview with Graham Lumsden the CEO of Motif BioSciences Inc. , the interview was from a few weeks and posted originally on Feb 5th a couple of days after Motif Bio announced they intended to float.

Note : the interview is with Graham Lumsden is the CEO of Motif Bio , not the AMP CEO who is Richard C. E. Morgan.

Well worth a listen.


hxxp://www....com/graham-lumsden-ceo-mofitbio-plc-ipo/


where ... is directorstalk

Quotes from interview

"Motif is in a very encouraging position in that we have a number of antibiotics in our pipeline"

"Looking to bring iclaprim to market hopefully within a 3 year period, early 2018"


In the interview the Motif Bio CEO also quotes two comparables with Motif.

1. PARATEK which is listed on Nasdaq on OCt 2014 and is about 6 months ahead of Motif. They are also taking a novel antibiotic into phase 3 , about to start phase 3 trials, their MCAP is currently about $345m.

2. DURATA , they got the first approval for their first product, an antibiotic in May 2014 and they were acquired later in the year by ACTAVIS for $675m.

[21trader] 18/3/2015 11:12

does not take long for a topinfo thread pump and dump to become fish and chip paper.

That thread should be closed down. The spikes and quick fall backs must be wiping out a lot of people stupid enough to follow the likes of flops, dorothy and falia !

[cottoner] 17/3/2015 14:24

Motif is a clinical stage biopharmaceutical company which specializes in developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria.

Motif Bio seem to be specialising in the right area at the right time.

.................

Innovation fund to support antibiotic development on the cards
The Pharmaceutical Journal , 12 MAR 2015

A global fund to encourage pharmaceutical companies to search for and develop new classes of antibiotics could be set up, the chair of the UK’s independent Review of Antimicrobial Resistance Jim O’Neill has indicated.

Speaking at the Pharma Summit, organised by the Economist Intelligence Unit, in London on 26 February 2015, O’Neill acknowledged that this was an unattractive area of research for the pharmaceutical industry because any new class of antibiotics was likely to be reserved for use only when existing drugs had failed.

Support mechanisms and incentives could include some form of global innovation fund, worth up to US$2bn, he said, more details of which will be unveiled officially in May 2015.

[tidy 2] 17/3/2015 13:12

M4 NCT now 370m vol

[moreforus] 17/3/2015 12:54

MP 167k buy at 2.98

Ian.B
Posts: 7,458
Premium Chat Member
Off Topic
Opinion: No Opinion
Price: 2.88
View Thread (2)RE: From Motif RNS

Today 12:45

thanks jim knew id read they had 56% this morning but couldn't put my finger back on n it as looked at so many reports on companies today.

so potentially £30m in value to amp there - pre ipo and any dilution with placing's.

[moreforus] 17/3/2015 12:52

Jimzi
Posts: 1,727
Premium Chat Member
Off Topic
Opinion: No Opinion
Price: 2.88
View Thread (2)From Motif RNS

Today 12:39

Amphion Innovations Group
*28,320,875 = 56.58%.....
...
*The collective holding by Amphion Innovations Group before Admission is made up of Amphion Innovations plc which holds 27,961,625 Motif ordinary shares and has 55.86% of Motif's issued share capital and MSA Holding B.S.C., a 100% subsidiary of Amphion Innovations plc, which holds 359,250 Motif ordinary shares and has 0.72% of Motif's issued share capital.

[21trader] 17/3/2015 08:41

flopinfo pump and dump squad have arrived !

Now given what happened to NBR and RHM buyers have a decision to make. Pay 3.25-3.5p or wait until later this week and see if it goes cheaper again or maybe today because the pump and dumpers are on the case.

I have a few do not mind a spike to offload more.

[enviropaul] 17/3/2015 08:35

Maple Securities given 15p price target here


Maple Securities ‏@MapleSecurities 2m2 minutes ago
London AIM listed #AMP 15p price target on Motif IPO.
2 retweets 0 favorites
Reply Retweeted2 Favorite

[cottoner] 16/3/2015 17:52

News that have been waiting for - RNS issued @ 17.10 wrt IPO of Motif Bio.

Schedule 1 - not a lot of details yet, but should follow in subsequent Schedule 1 RNSes.

Securities to be admitted: TBC
Nominal value of securities: 1p
Issue price: 20p
Shares in treasury: Nil
There are no restrictions on the transfer of securities

Expected Admission Date : 31st March 2015.


The main thing is now it is very likely that the IPO is going to take place.

[21trader] 26/2/2015 07:41

Not the Rns I was expecting to see

[21trader] 24/2/2015 10:54

I'm getting full offer again online so maybe time for some upward movement.